Genmab (GMAB)
(Delayed Data from NSDQ)
$26.43 USD
-0.64 (-2.36%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $26.44 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Genmab A/S Sponsored ADR [GMAB]
Reports for Purchase
Showing records 1 - 20 ( 116 total )
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
EPKINLY Receives FDA Approval in R/R FL; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
European Hematology Association 2024 Congress Key Takeaways; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
Key ASCO Takeaways; Epcoritamab and Acasunlimab Shine; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
Eight Clinical Datasets Expected for Epcoritamab at EHA; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
1Q24 Financials; EPKINLY FDA Decision in r/r FL in June; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
TIVDAK Receives Full FDA Approval in r/r Cervical Cancer; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
ProfoundBio Deal Adds ADCs to Genmab''s Armory; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
DARZALEX NICE-Endorsed in Newly-Diagnosed AL Amyloidosis; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
EPKINLY Supplemental Biologics License Application in r/r FL; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
2023 Financials Reported; Numerous Catalysts Expected in 2024; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
DARZALEX 2023 Sales Reported; Genmab Appeal Denied; Modulating PT to $50
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
Numerous Datasets Presented at ASH Conference; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
Epcoritamab Positive Follicular Lymphoma Regulatory Feedback; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GMAB 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
sBLA Submitted For RYBREVANT + Chemo in EGFR+ NSCLC Post-Tagrisso; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple Datasets Expected at ASH; 3Q23 Financials; Modulating PT to $49
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
TIVDAK and RYBREVANT Both Shine at ESMO; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
3Q23 DARZALEX Sales Announced; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
Epcoritamab Obtains Conditional European Marketing Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Genmab A/S Sponsored ADR
Industry: Medical - Biomedical and Genetics
TIVDAK InnovaTV-301 Trial Meets Overall Survival Endpoint; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R